CRT 2025
Coronary
Complex PCI Sunday
Karim Al-Azizi, MD, FACC, FSCAI, FESC
Medical Director, Cardiac Catheterization Laboratories
The Heart Hospital, Baylor Scott & White Health
Baylor Scott & White
Frisco, Texas, United States
Disclosure(s): Abbott Labs: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); shockwave: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Srini Potluri, MD
Chief of Cardiology
Baylor Scott and White The Heart Hospital Plano
Frisco, Texas, United States
Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips, Endovascular Engineering, Abiomed, Terumo, SpectraWAVE: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Sibi Thomas, DO
Baylor Scott and White The Heart Hospital Plano
Disclosure information not submitted.
Lindsey Cilia, MD
Co-Director of Complex Coronary Therapeutics Program
Interventional Cardiologist
Inova Heart and Vascular Institute/Virginia Heart
Falls Church, Virginia, United States
Disclosure(s): No financial relationships to disclose
F. Aaysha Cader, MD MRCP MSc (Oxon)
Cardiology Registrar
Kettering General Hospital, UK
Kettering, England, United Kingdom
Disclosure(s): No financial relationships to disclose
Abdulla A. Damluji, MD, PhD, MBA
Interventional Cardiologist
Inova Heart and Vascular Institute
Fairfax, Virginia, United States
Disclosure(s): No financial relationships to disclose
Ashequl M. Islam, MD
Assoc Chief of Cardiology and Director of Valve Program and Interventional Cardiology Fellowship; Director, Heart and Vascular Program Strategy
Baystate Medical Center
Springfield, Massachusetts, United States
Disclosure(s): No financial relationships to disclose
David E. Kandzari, MD, FACC, FSCAI
Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States
Disclosure(s): Abbott Vascular: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Ablative Solutions, Inc.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); DeepQure: Consulting Fees (e.g., advisory boards) (Ongoing); GoldenLeaf Medical: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Supira Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)
Hady Lichaa, MD
Interventional Cardiovascular Specialist
Ascension Saint Thomas Hospital
Murfreesboro, Tennessee, United States
Disclosure(s): Abbott Vascular, Abiomed, Philips, Penumbra, shockwave and Medtronic.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Rajesh Sachdeva, MD, FACC, FSCAI
Staff Physician
Atlanta VA Medical Center, Georgia, United States
Disclosure(s): No financial relationships to disclose
Fayaz Shawl, MD, FACC, FACP, FSCAI
Director, Interventional Cardiology
Adventist HeathCare WhiteOak Medical Center
Silver Spring , Maryland, United States
Disclosure(s): No financial relationships to disclose